The design, fabrication, characterization, and preclinical evaluation of novel nanoparticle-based drug formulations capable of delivering candidate RNAi therapeutics for the treatment of cancer.
Project Terms: base; cancer therapy; design; Drug Formulations; Malignant Neoplasms; nanoparticle; Nanotechnology; novel; Phase; preclinical evaluation; RNA Interference; Small Business Innovation Research Grant; Therapeutic; Therapeutic Uses